In compliance with the cGMP & ICH Guideline, Langhua established a robust quality system and maintains a good track record of on-site cGMP inspections performed by both global regulatory authorities such as USFDA, EMPA, EDQM, WHO, ANVISA, etc., and the multinational pharmaceutical companies.
Our experienced quality team is committed to ensuring the services we provide to our clients, the products we develop or manufacture, can conform to the specifications and compliance with the regulatory authority's quality requirement, in the product's whole life cycle from pre-clinical, and clinical phase, through to post-approval.
